Neuphoria Therapeutics Inc. (NEUP) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Neuphoria Therapeutics Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEUP
Neuphoria Therapeutics Inc.
$3.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PTN
Palatin Technologies, Inc.
$9.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NEUP vs PTN
growth of $100 · dividends reinvested · last 5yNEUP -98.0% (-54.5%/yr)PTN -98.7% (-58.0%/yr)NEUP compounded faster over this window
NEUP PTN
NEUP vs PTN: by the numbers
- •NEUP is the larger company ($19M vs $17M market cap).
- •Both run net losses; PTN's is the smaller (-63.54% vs -1578.40% net margin).
Metrics side by side
Valuation
| Metric | NEUP | PTN |
|---|---|---|
| P/S ratio | 15.88 | 1.27 |
| P/B ratio | 0.76 | 2.50 |
Profitability
| Metric | NEUP | PTN |
|---|---|---|
| Gross margin | 43.54% | 99.63% |
| Operating margin | -835.53% | -65.74% |
| Net margin | -1578.40% | -63.54% |
| ROE | -75.34% | -125.30% |
| ROIC | -49.83% | -125.44% |
Growth (annualized)
| Metric | NEUP | PTN |
|---|---|---|
| Revenue CAGR (5Y) | 11.12% | N/A |
| Total return CAGR (5Y) | N/A | -55.41% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.